1. PTH-088 Prevalence of low drug levels and anti-drug antibodies in an unscreened population of patients with inflammatory bowel disease receiving infliximab. (17th June 2017) Authors: Downey, R; Tun, G; Swallow, K; Wild, G; Robinson, K; Wright, A; Marshall, L; Hale, M; Sargur, R; Lobo, AJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTH-110 Antibodies to infliximaboccur throughout treatment but development is delayed by immunosuppression. (17th June 2017) Authors: Downey, R; Tun, G; Swallow, K; Wild, G; Robinson, K; Wright, A; Marshall, L; Hale, M; Sargur, R; Lobo, AJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTH-152 The Patient Perspective of a Nurse-Led Inflammatory Bowel Disease (IBD) Telephone Helpline Service. (17th August 2016) Authors: Rezwan, N; West, D; Tun, G; Shirazi-Nejad, A; Kapur, K; Bullas, D; Soliman, A; Sathyanarayana, V; Atkinson, R; Said, E Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗